|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 14, 2019 ) Asia-Pacific Conjugate Vaccine Market:Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. Asia Pacific is the fastest growing market for conjugate vaccines. The conjugate vaccines market in Asia-Pacific is expected to expand at a CAGR of 23.5%, leading to a revenue of USD 66.61 Bn by 2023. By volume, it is anticipated to reach 6,883.55 Million units by 2023, expanding at a CAGR of 21.87%.
A penetration rate of around 95% of DTP conjugate vaccines indicates an excellent coverage in Asia-Pacific countries and very little is left to achieve full penetration for the vaccines. Countries with high populations such as China and India, serve as major target areas for such vaccines, and the introduction of these vaccines would ensure a disease-free society.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/asia-pacific-conjugate-vaccine-market/11298/#requestforsample
Market Segmentation:
By disease indication, the market is segmented into:
o Pneumococcal
o Haemophilus influenza type B
o Diphtheria-tetanus-pertussis
o Meningococcal
o Others
By end user, the market is segmented into:
o Paediatric
o Adult
By countries, the Asia-Pacific market is divided into:
o China
o India
o Japan
o South Korea
......
Get Discount & Customization of this Report Here:https://www.researchreporthub.com/report/asia-pacific-conjugate-vaccine-market/11298/
Table Of Content
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary - II
Chapter 2: Market overview
2.1. Market definitions
2.2. Asia-Pacific market overview – by revenue
- Asia-Pacific historical (2015-2017) market revenue (USD Bn)
- Asia-Pacific forecasted (2018-2023) market revenue (USD Bn)
- Country-wise market (2018-2023) revenue (USD Bn)
2.3. Asia-Pacific market overview – by volume
- Asia-Pacific historical (2015-2017) market volume (Million units)
- Asia-Pacific forecasted (2018-2023) market volume (Million units)
- Country-wise (2018-2023) market volume (Million units)
2.4. Asia-Pacific market drivers and challenges
2.4.1. Asia-Pacific market drivers
2.4.2. Asia-Pacific market challenges
2.5. Asia-Pacific market trends
2.6. Value chain
2.7.1. Country-specific market overview – China
- Observation
- Key competitors
2.7.1(A) Country-specific market overview – China by revenue and by volume
- China historical (2015-2017) market revenue (USD Bn)
- China forecasted (2018-2023) market revenue (USD Bn)
- China historical (2015-2017) market volume (Million units)
- China forecasted (2018-2023) market volume (Million units)
2.7.2. Country-specific market overview – India
- Observation
- Key competitors
2.7.2(A) Country-specific market overview – India by revenue and by volume
- India historical (2015-2017) market revenue (USD Bn)
- India forecasted (2018-2023) market revenue (USD Bn)
- India historical (2015-2017) market volume (Million units)
- India forecasted (2018-2023) market volume (Million units)
2.7.3. Country-specific market overview – Japan
- Observation
- Key competitors
2.7.3(A) Country-specific market overview – Japan-by revenue and by volume
- Japan historical (2015-2017) market revenue (USD Bn)
- Japan forecasted (2018-2023) market revenue (USD Bn)
- Japan historical (2015-2017) market volume (Million units)
- Japan forecasted (2018-2023) market volume (Million units)
2.7.4. Country-specific market overview – South Korea
- Observation
- Key competitors
2.7.3(A) Country-specific market overview – South Korea-by revenue and by volume
- South Korea historical (2015-2017) market revenue (USD Bn)
- South Korea forecasted (2018-2023) market revenue (USD Bn)
- South Korea historical (2015-2017) market volume (Million units)
- South Korea forecasted (2018-2023) market volume (Million units)
Chapter 3: Asia-Pacific major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal – Asia-Pacific (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib – Asia-Pacific (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP – Asia-Pacific (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal – Asia-Pacific (USD Bn, Million units)
......
Get Complete TOC with Figures and Tables Here:https://www.researchreporthub.com/report/asia-pacific-conjugate-vaccine-market/11298/#toc
Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
About US
Research Report Hub
Sector 04, Plot 101, Sant Nagar,
Moshi PCNDTA, Pune, 412105
Maharashtra, India
Web:www.researchreporthub.com
Find us on:
https://www.facebook.com/reasearchreporthub/
https://twitter.com/hub_report
https://www.linkedin.com/company/research-report-hub/
Research Report Hub
Prakriti Mathur
+918448444687
sales@researchreporthub.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
